Arylpyrrolidines as narcotic antagonists.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004357:Drug Synergism; D004361:Drug Tolerance; D000882:Haplorhini; D006801:Humans; D008251:Macaca; D008968:Molecular Conformation; D009020:Morphine / Q000037:antagonists & inhibitors; D009269:Nalorphine / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced; D019966:Substance-Related Disorders / Q000188:drug therapy
D000700:Analgesics; D009292:Narcotic Antagonists; D010636:Phenols; D011759:Pyrrolidines; D009020:Morphine; D009269:Nalorphine